Left ventricular remodeling following septal myectomy in hypertrophic obstructive cardiomyopathy

Tsuyoshi Yamabe1,2, Jonathan Ginns3, Vijay Vedula4

  • 1Division of Cardiothoracic and Vascular Surgery, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY.

JTCVS Open
|September 29, 2022
PubMed

Insights

Septal myectomy for obstructive hypertrophic cardiomyopathy can remodel the entire left ventricle, not just the removed section. This surgery effectively reduces heart muscle thickness and improves outflow tract gradients.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Imaging

Background:

  • Obstructive hypertrophic cardiomyopathy (HCM) is a condition characterized by thickening of the heart muscle.
  • Septal myectomy is a surgical procedure to relieve the obstruction.
  • The extent of left ventricular remodeling after septal myectomy is not fully understood.

Purpose of the Study:

  • To investigate left ventricular remodeling following septal myectomy in patients with obstructive HCM.
  • To determine the mechanism and extent of this remodeling using cardiac computed tomography.

Main Methods:

  • Retrospective review of 50 patients with obstructive HCM who underwent septal myectomy.
  • Postoperative cardiac computed tomography (CT) in 19 patients.
  • Measurement of septal band volume and left ventricular myocardial segment thickness using CT to assess changes.

Main Results:

  • Septal myectomy significantly reduced the left ventricular outflow tract pressure gradient and septal thickness.
  • Mitral regurgitation and systolic anterior motion were markedly decreased post-surgery.
  • Total left ventricular myocardial volume reduction exceeded the resected septal band volume, indicating global remodeling.

Conclusions:

  • Septal myectomy effectively alleviates obstruction in obstructive HCM.
  • The procedure induces remodeling of the entire left ventricle, beyond the surgically resected area.
  • Cardiac CT is valuable for assessing these volumetric and dimensional changes.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
29
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
22
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
27
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
21